Evidence map›Paper›PMID 31685649›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2019

Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission.

Esi Domi, Francesca Felicia Caputi, Patrizia Romualdi, Ana Domi, Giulia Scuppa, Sanzio Candeletti, Alison Atkins, Markus Heilig, Gregory Demopulos, George Gaitanaris and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Activation of GABANeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Esi DomiSchool of Pharmacy, Pharmacology Unit, University of Camerino, Camerino 62032, Italy.
Francesca Felicia CaputiDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Bologna, 40126 Italy.
Patrizia RomualdiDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Bologna, 40126 Italy.
Ana DomiSchool of Pharmacy, Pharmacology Unit, University of Camerino, Camerino 62032, Italy.
Giulia ScuppaSchool of Pharmacy, Pharmacology Unit, University of Camerino, Camerino 62032, Italy.
Sanzio CandelettiDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Bologna, 40126 Italy.
Alison AtkinsCenter for Social and Affective Neuroscience, IKE, Linköping University, Linköping, 58183, Sweden, and.
Markus HeiligCenter for Social and Affective Neuroscience, IKE, Linköping University, Linköping, 58183, Sweden, and.ORCID 0000-0003-2706-2482
Gregory DemopulosOmeros Corporation, Seattle, Washington 98101.
George GaitanarisOmeros Corporation, Seattle, Washington 98101.
Roberto CiccocioppoSchool of Pharmacy, Pharmacology Unit, University of Camerino, Camerino 62032, Italy, roberto.ciccocioppo@unicam.it.
Massimo UbaldiSchool of Pharmacy, Pharmacology Unit, University of Camerino, Camerino 62032, Italy.ORCID 0000-0002-4089-2483
Università di Camerino · ITLinköping University · SEUniversity of Bologna · ITOmeros Corporation (United States) · US

Funding

Viral Vector CoreP60AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARISA ROBERTO · 2003 to 2026
$46.3M
The Nociceptin ORL1 System: Treatment Target for RelapseR01AA014351 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI Friedbert Weiss · 2004 to 2026
$7.3M
Regulation of Ethanol Effects on Synaptic TransmissionR01AA015566 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2006 to 2019
$4.6M
Neuroplasticity of the Extended Amygdala CRF circuitry in alcohol dependenceR01AA021491 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2013 to 2024
$3.9M
Gene-environment interaction: the brain CRF system in alcohol preferring msP ratsR37AA017447 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2016 to 2025
$3.7M
Neuroimmune mechanisms in stress and alcohol comorbidityR01AA027700 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2019 to 2023
$2.4M
Gene-environment interaction: the brain CRF system in alcohol preferring msP ratsR01AA017447 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2009 to 2013
$1.8M
NIAAA NIH HHS P60 AA006420NIAAA NIH HHS R01 AA014351NIAAA NIH HHS R01 AA015566NIAAA NIH HHS R01 AA017447NIAAA NIH HHS R01 AA021491NIAAA NIH HHS R01 AA027700NIAAA NIH HHS R37 AA017447
6 · The paper itself

Abstract

An isoform of peroxisome proliferator-activated receptors (PPARs), PPARγ, is the receptor for the thiazolidinedione class of anti-diabetic medications including pioglitazone. Neuroanatomical data indicate PPARγ localization in brain areas involved in drug addiction. Preclinical and clinical data have shown that pioglitazone reduces alcohol and opioid self-administration, relapse to drug seeking, and plays a role in emotional responses. Here, we investigated the behavioral effect of PPARγ manipulation on nicotine withdrawal in male Wistar rats and in male mice with neuron-specific PPARγ deletion (PPARγ

Indexed as

Synaptic TransmissionAffectAmygdalaAnilidesAnimalsAnxietyBehavior, Animalgamma-Aminobutyric AcidHippocampusMaleMice, KnockoutMicroinjectionsNeuronsPioglitazonePPAR gammaRats2-chloro-5-nitrobenzanilideAnilidesgamma-Aminobutyric AcidPioglitazonePPAR gammaaddictionnicotinepioglitazonePPARγwithdrawal

Identifiers

PMID31685649
PMCPMC6891057
OpenAlexW2985416173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.